- Home
- AUTL vs VREX Comparison
AUTL vs VREX Comparison
Compare AUTL & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUTL | VREX |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 431.2M | 580.6M |
| IPO Year | 2025 | 2016 |
Fundamental Metrics
Financial Performance| Metric | AUTL | VREX |
|---|---|---|
| Price | $1.33 | $10.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $8.50 | ★ $16.67 |
| AVG Volume (30 Days) | ★ 1.4M | 247.8K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.33 | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | $10,120,000.00 | ★ $811,000,000.00 |
| Revenue This Year | $669.62 | $5.35 |
| Revenue Next Year | $79.78 | $3.88 |
| P/E Ratio | ★ N/A | $213.00 |
| Revenue Growth | ★ 496.00 | N/A |
| 52 Week Low | $1.11 | $6.76 |
| 52 Week High | $2.70 | $14.57 |
Technical Indicators
Market Signals| Indicator | AUTL | VREX |
|---|---|---|
| Relative Strength Index (RSI) | 37.41 | 28.40 |
| Support Level | $1.27 | $9.81 |
| Resistance Level | $1.52 | $12.61 |
| Average True Range (ATR) | 0.08 | 0.44 |
| MACD | -0.03 | -0.06 |
| Stochastic Oscillator | 1.47 | 9.13 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About VREX Varex Imaging Corporation
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.